Technical Analysis for INSM - Insmed, Inc.

Grade Last Price % Change Price Change
grade C 20.28 5.57% 1.07
INSM closed up 5.57 percent on Friday, November 15, 2019, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical INSM trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Inside Day Range Contraction 5.57%
Outside Day Range Expansion 4.27%
Doji - Bearish? Reversal 6.79%
Spinning Top Other 6.51%

Older signals for INSM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company's Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.
Biopharmaceutical Medical Specialties Infectious Diseases Cystic Fibrosis Infectious Causes Of Cancer Microbiology Bacterial Diseases Bacteriology Tuberculosis Pseudomonas Mycobacterium Nontuberculous Mycobacteria
Is INSM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 33.13
52 Week Low 11.31
Average Volume 1,109,644
200-Day Moving Average 23.4998
50-Day Moving Average 18.2916
20-Day Moving Average 18.693
10-Day Moving Average 19.183
Average True Range 0.8692
ADX 15.63
+DI 28.9491
-DI 14.5703
Chandelier Exit (Long, 3 ATRs ) 17.6924
Chandelier Exit (Short, 3 ATRs ) 19.3876
Upper Bollinger Band 20.2
Lower Bollinger Band 17.186
Percent B (%b) 1.03
BandWidth 16.123683
MACD Line 0.4621
MACD Signal Line 0.3383
MACD Histogram 0.1237
Fundamentals Value
Market Cap 1.27 Billion
Num Shares 62.4 Million
EPS -3.04
Price-to-Earnings (P/E) Ratio -6.67
Price-to-Sales 0.00
Price-to-Book 20.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.63
Resistance 3 (R3) 21.49 20.89 21.41
Resistance 2 (R2) 20.89 20.55 20.97 21.33
Resistance 1 (R1) 20.59 20.34 20.74 20.73 21.25
Pivot Point 19.99 19.99 20.07 20.07 19.99
Support 1 (S1) 19.69 19.65 19.84 19.83 19.31
Support 2 (S2) 19.09 19.44 19.17 19.23
Support 3 (S3) 18.79 19.09 19.16
Support 4 (S4) 18.93